ArticleOncology letters2019

Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3

Michele Massimino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.